4//SEC Filing
Nolan Mangini Siobhan 4
Accession 0001209191-22-040348
CIK 0001426332other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 6:36 PM ET
Size
5.6 KB
Accession
0001209191-22-040348
Insider Transaction Report
Form 4
Nolan Mangini Siobhan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-07-01+100,000→ 100,000 totalExercise: $12.78Exp: 2032-06-30→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option vest over a four-year period measured from from July 1, 2022, with 1/48th of the shares vesting on a monthly basis, subject to the reporting person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan) as of each such vesting date.
Documents
Issuer
NGM BIOPHARMACEUTICALS INC
CIK 0001426332
Entity typeother
Related Parties
1- filerCIK 0001679464
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 6:36 PM ET
- Size
- 5.6 KB